Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)
Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)
Not yet recruiting · NCT06802848 · Registry updated 2025-01-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real) | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, arthritic joint disease, arthropathy, bone disorder, musculoskeletal system disorder, psoriasis, psoriatic arthritis, skin disorder, spondylitis, vertebral column disorder | Not yet recruiting | Not stated | 2025-01-31 | NCT06802848 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chongqing Genrix Biopharmaceutical Co., Ltd | 1 |
| Xiangya Hospital of Central South University | 162 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Xiangya Hospital of Central South University | Hunan | China | 3 |